Earnings Per Share, Basic in USD/shares of Entrada Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Entrada Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q3 2025.
  • Entrada Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -1.06 USD/shares, a 203% decline year-over-year.
  • Entrada Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -2 USD/shares, a 262% decline year-over-year.
  • Entrada Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was 1.76 USD/shares.
  • Entrada Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.2 USD/shares, a 93.4% increase from 2022.
  • Entrada Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.02 USD/shares, a 63% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Entrada Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2 -$1 -$1 -203% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$2 -$1 -$3 -165% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $0 $0 -$1 -160% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $1.00 $0 +$0.08 +28.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $1.00 $0 -$1 -133% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $3.00 $1.61 +$2.39 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $0 $0.70 +$0.91 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $0 $0 +$0.51 +64.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $0 $1.07 +$1.87 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$2 -$1 $0 -5.41% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2 $0 +$0.48 +69.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$3 -$1 -$17 -105% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $13.00 -$1 +$8.98 +91.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $4.00 -$1 +$6.82 +90.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$2 -$1 +$5.98 +89.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$8 $15.90 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$10 -$4 -59.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$8 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$7 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$6 Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-09

Entrada Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.76 +$1.96 Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $0 +$2.82 +93.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$3 +$5.14 +63% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$8 +$15.80 +66% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$24 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.